AI takes aim at brain cancer: smart radiation trial seeks better control
NCT ID NCT06492486
Summary
This study is testing a new AI-guided method for delivering radiation therapy to people with glioma, a type of brain tumor. The goal is to see if using artificial intelligence to adjust radiation doses based on frequent MRI and PET scans during treatment can better control the tumor and reduce side effects. The trial will involve 60 patients and aims to develop a more precise and adaptable treatment workflow.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.